"Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 10534334)

Published in Hepatology on November 01, 1999

Authors

M Sebagh1, M Debette, D Samuel, J F Emile, B Falissard, V Cailliez, D Shouval, H Bismuth, M Reynès

Author Affiliations

1: Service d'Anatomie Pathologique, Hôpital Paul Brousse, Villejuif, UPRES "virus hépatotropes et cancers," Université Paris-Sud, France. mylene.sebagh@pbr.ap-hop-paris.fr

Articles by these authors

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science (1998) 4.58

Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med (1993) 4.43

Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 4.17

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med (1992) 4.05

Surgical anatomy and anatomical surgery of the liver. World J Surg (1982) 3.96

Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med (1981) 3.17

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12

Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol (1999) 2.80

Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76

Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature (1980) 2.72

Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery (1984) 2.63

Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60

Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology (2000) 2.46

Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol (2001) 2.43

Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg (1997) 2.28

Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg (1988) 2.26

Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg (2000) 2.16

Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics (1996) 2.14

Audit of pain after nasal surgery. Ann R Coll Surg Engl (1996) 2.10

Liver resections in cirrhotic patients: a Western experience. World J Surg (1986) 2.05

Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg (2003) 2.04

Mortality gradient across the labour market core-periphery structure: a 13-year mortality follow-up study in north-eastern France. Int Arch Occup Environ Health (2013) 2.00

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology (1995) 2.00

Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99

Repeat hepatectomy for colorectal liver metastases. Ann Surg (1997) 1.99

Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis (1997) 1.96

Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant (2010) 1.93

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86

Long term results of Roux-en-Y hepaticojejunostomy. Surg Gynecol Obstet (1978) 1.85

Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med (1997) 1.83

Identification of cryptosporidium oocysts by monoclonal antibody. Lancet (1987) 1.79

Partial portacaval shunt: renaissance of an old concept. Surgery (1992) 1.79

Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg (2010) 1.72

Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis (2001) 1.71

Short- and long-term donor morbidity in right lobe living donor liver transplantation: 91 consecutive cases in a European Center. Am J Transplant (2011) 1.70

Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68

Laparoscopic liver resection of benign liver tumors. Surg Endosc (2002) 1.68

Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet (1992) 1.68

Major and minor segmentectomies "réglées" in liver surgery. World J Surg (1982) 1.65

The use of operative ultrasound in surgery of primary liver tumors. World J Surg (1987) 1.64

Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology (1985) 1.62

Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg (1988) 1.61

Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis (2000) 1.58

Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56

Bronchobiliary fistulas in adults. Ann Surg (1988) 1.55

Infected endometriotic cysts secondary to oocyte aspiration for in-vitro fertilization. Hum Reprod (1994) 1.53

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol (2003) 1.53

Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant (2012) 1.53

Chlorhexidine compared with povidone-iodine as skin preparation before blood culture. A randomized, controlled trial. Ann Intern Med (1999) 1.52

Gallbladder cancer: the polyp-cancer sequence. Br J Surg (1990) 1.50

The presence of epithelioid granulomas in hepatitis C virus-related cirrhosis. Hum Pathol (1993) 1.50

Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol (1993) 1.49

Evaluation of urinary antigen ELISA for diagnosing Legionella pneumophila serogroup 1 infection. J Clin Pathol (1990) 1.49

Hematobilia resulting from heterotopic stomach in the gallbladder neck. Surgery (1989) 1.48

Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46

Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. J Infect Dis (1999) 1.45

Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest (1992) 1.45

Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45

Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg (1974) 1.43

Postpartum Budd-Chiari syndrome with prolonged hypercoagulability state. Am J Obstet Gynecol (1990) 1.42

Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol (1999) 1.42

Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci U S A (1980) 1.41

[Living donor in liver transplantation. Present and future alternatives]. Gastroenterol Clin Biol (2000) 1.40

Primary biliary cirrhosis in Israel. Isr J Med Sci (1992) 1.39

Fulminant non--A-G viral hepatitis leading to liver transplantation. Arch Intern Med (2000) 1.39

Comparison of methods for extraction of nucleic acid from hemolytic serum for PCR amplification of hepatitis B virus DNA sequences. J Clin Microbiol (1997) 1.39

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38

[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience]. Gastroenterol Clin Biol (2001) 1.38

Emergency orthotopic liver transplantation in two patients using one donor liver. Br J Surg (1989) 1.38

The course of hepatitis C virus infection after liver transplantation. Hepatology (1994) 1.38

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology (1993) 1.36

Hepatocellular carcinoma. Br J Surg (1998) 1.35

Split-liver transplantation. The Paul Brousse policy. Ann Surg (1996) 1.35

Impact of reminders and method of questionnaire distribution on patient response to mail-back satisfaction survey. J Clin Epidemiol (2001) 1.35

Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J Infect Dis (2001) 1.34

Segmental liver resection using ultrasound-guided selective portal venous occlusion. Ann Surg (1989) 1.32

Hepatitis A booster vaccination: is there a need? Lancet (2003) 1.32

Alleviation of drug withdrawal symptoms by treatment with a potent mixture of natural lipids. Eur J Pharmacol (1982) 1.31